Ocala GI Research — Ocala, Florida

Ocala GI Research is a clinical research site located in Ocala, Florida, United States 34471.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Ocala GI Research has participated in 10 clinical trials with 6 currently active.

Therapeutic areas: Metabolic Dysfunction-associated Steatohepatitis, Ulcerative Colitis, Non-alcoholic Steatohepatitis.

Sponsors: Eccogene, Abivax S.A., Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ocala GI Research?

Ocala GI Research has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ocala GI Research conducted?

Ocala GI Research has 10 clinical trials on record, with 6 currently active. Their work covers Metabolic Dysfunction-associated Steatohepatitis, Ulcerative Colitis, Non-alcoholic Steatohepatitis.

Is Ocala GI Research accredited by Crixeo Health?

Yes — Ocala GI Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Ocala GI Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.